Molecular pathological epidemiology – managing cancer heterogeneity

Host: Richard Wilson, Queen's University Belfast


Room: Default Location

Molecular Pathological Epidemiology (MPE, also molecular pathologic epidemiology) involves the high-throughput biological interrogation of samples from large patient cohorts, collected with epidemiological intent, aiming to elucidate the heterogeneity of disease. To do so, pathology tools are adapted to high-throughput analysis linked with data related to lifestyle, risk factors and drug history, among others.

This session will present some of the best examples to date of science derived by this approach, in the areas of upper GI, lower GI and breast cancer, and will review the technical aspects of large cohort sample interrogation.

The session is intended to inform epidemiologists, pathologists and scientists and clinicians willing to engage with platforms able to provide a population-based dimension to basic cancer biology.

Confirmed speakers:
Shuji Ogino, Harvard Medical School, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital
Piet A. van Den Brandt, Department of Epidemiology, Maastricht University
Helen Coleman, Centre for Public Health, Queen’s University Belfast